# Low-Dose Rituximab in the Treatment of Primary Membranous Nephropathy - A Systematic Review and Meta-Analysis.

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/low-dose-rituximab-in-the-treatment-of-primary-membranous-nephropathy-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Gerry George Mathew,Shanmugam Sundaramurthy,Prakash Muthuperumal,Varadharajan Jayaprakash |
| Citations | 2 |
| DOI | 10.69097/41-05-2024-04 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4404392153 |
| PMID | 39508703 |
| Type | review |
| Year | 2024 |

## Paper authors

- [Gerry George Mathew](https://scholariq.org/researchers/gerry-george-mathew/)
- [Shanmugam Sundaramurthy](https://scholariq.org/researchers/shanmugam-sundaramurthy/)
- [Prakash Muthuperumal](https://scholariq.org/researchers/prakash-muthuperumal/)
- [Varadharajan Jayaprakash](https://scholariq.org/researchers/varadharajan-jayaprakash/)

## Paper journal

- [PubMed](https://scholariq.org/journals/pubmed/)

## Paper primary topic

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

## Paper topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.